Sms Pharmaceuticals Ltd logo

Sms Pharmaceuticals Ltd (SMSPHARMA)

Market Closed
7 Aug, 22:00
MSE MSE
377. 30
+20.1
+5.6271%
- Market Cap
- P/E Ratio
1.2% Div Yield
21,882 Volume
- Eps
357.2
Previous Close
Add Transaction
Day Range
359 380.5
Year Range
208.2 446.5
Want to track SMSPHARMA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

SMSPHARMA closed Friday higher at ₹377.3, an increase of 5.6271% from Thursday's close, completing a monthly decrease of -8.8317% or -₹36.55. Over the past 12 months, SMSPHARMA stock gained 23.0192%.
SMSPHARMA pays dividends to its shareholders, with the most recent payment made on Oct 29, 2025. The next announced payment will be in In 1 month on Sep 23, 2026 for a total of ₹0.4.
The last earnings report, released on May 28, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 1.7821%, based on the last three reports.
Sms Pharmaceuticals Ltd has completed 1 stock splits, with the recent split occurring on Dec 17, 2015.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XNSE (INR).

SMSPHARMA Chart

Sms Pharmaceuticals Ltd (SMSPHARMA) FAQ

What is the stock price today?

The current price is ₹377.30.

On which exchange is it traded?

Sms Pharmaceuticals Ltd is listed on MSE.

What is its stock symbol?

The ticker symbol is SMSPHARMA.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.2%.

What is its market cap?

As of today, no market cap data is available.

Has Sms Pharmaceuticals Ltd ever had a stock split?

Sms Pharmaceuticals Ltd had 1 splits and the recent split was on Dec 17, 2015.

Sms Pharmaceuticals Ltd Profile

Pharmaceuticals Industry
Healthcare Sector
- CEO
MSE Exchange
INE812G01025 ISIN
India Country
1,095 Employees
16 Sep 2026 Last Dividend
17 Dec 2015 Last Split
- IPO Date

Overview

SMS Pharmaceuticals Limited is a prominent player in the pharmaceutical industry based in Hyderabad, India, specializing in the production and sale of active pharmaceutical ingredients (APIs) and intermediates. Since its establishment in 1987, the company has dedicated itself to the development and manufacture of a wide range of pharmaceutical products, catering to various therapeutic categories. In addition to its robust product portfolio, SMS Pharmaceuticals is engaged in contract research activities, showcasing its versatile capabilities in the pharmaceutical sector. The company’s commitment to quality and innovation has enabled it to not only meet the demand within India but also export its products to international markets, reinforcing its position as a key global pharmaceutical manufacturer.

Products and Services

  • Anti-ulcer Products: These medications are designed to alleviate symptoms and promote healing of ulcers in the stomach and intestines. SMS Pharmaceuticals offers effective solutions for managing ulcer-related disorders.
  • Anti-fungal Products: Targeted at combating fungal infections, these products are formulated to inhibit the growth of fungi, proving essential in treating skin, nail, and systemic fungal infections.
  • Anti-migraine Products: SMS Pharmaceuticals provides medications that are intended to relieve migraine symptoms, helping to reduce the frequency and severity of migraine headaches.
  • Anti-diabetic Products: Catering to a growing need, these products help in the management of diabetes by regulating blood sugar levels, offering essential support to diabetic patients.
  • Anti-epileptic Products: These are used in the treatment of epilepsy, helping to control seizures and improve the quality of life for those affected by this condition.
  • Anti-psychotic Products: Aimed at treating psychiatric disorders, these medications play a crucial role in managing symptoms and improving mental health.
  • Anti-inflammatory Products: These products are designed to reduce inflammation and relieve pain, finding applications in various medical conditions from acute injuries to chronic diseases.
  • Anti-viral Products: In the fight against viral infections, these medications are vital. They work by inhibiting the reproduction of viruses, helping to treat conditions like HIV, hepatitis, and more.
  • Anti-coagulant Products: These are crucial in preventing blood clots, thereby reducing the risk of stroke, heart attack, and other serious conditions.
  • Anti-retroviral Products: Specific to the treatment of HIV/AIDS, these drugs suppress the virus, reducing its impact and prolonging lives.
  • Contract Research Activities: Beyond manufacturing pharmaceuticals, SMS Pharmaceuticals is involved in contract research, offering specialized services to support drug development and innovation in the pharmaceutical industry.

Contact Information

Address: Plot No. 72
Phone: 91 40 2525 9999